About Jaime Contreras
Form D filings for 32 Biosciences in 2024 list Jaime Contreras as director.
Jaime Contreras first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jaime Contreras in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jaime Contreras works with at each company, as listed on that company's latest Form D.
32 Biosciences, Inc. · Form D, May 31, 2024
JP
Joseph Pierre
Director
BY
Brian Yoor
Director
EC
Eugene Chang
Director
JA
John Alverdy
Director
PF
Peter Farmakis
Chief Executive Officer and director